ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.22
-0.93%
US Tech 100
18,488.00
-0.25%
S&P 500
5,346.99
-0.11%
US Dollar vs CAD
1.37725
-0.03%
Bitcoin
69,342.31
0.01%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Athira Pharma Inc (ATHA)

  7. Athira Pharma Inc (ATHA) News

ATHA

Athira Pharma (ATHA)

Athira Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATHA
DateTimeSourceHeadlineSymbolCompany
05/29/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHAAthira Pharma Inc
05/29/20246:00AMGlobeNewswire Inc.Athira Pharma to Participate in Upcoming June ConferencesNASDAQ:ATHAAthira Pharma Inc
05/24/20246:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
05/24/20245:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
05/24/20245:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
05/17/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHAAthira Pharma Inc
05/17/20244:00PMGlobeNewswire Inc.Athira Pharma Announces Proposed Settlement of Stockholder Derivative ActionNASDAQ:ATHAAthira Pharma Inc
05/15/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHAAthira Pharma Inc
05/15/20243:05PMGlobeNewswire Inc.Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business UpdatesNASDAQ:ATHAAthira Pharma Inc
05/02/20246:00AMGlobeNewswire Inc.Athira Pharma to Participate in Upcoming May ConferencesNASDAQ:ATHAAthira Pharma Inc
04/15/20246:00AMGlobeNewswire Inc.Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical OfficerNASDAQ:ATHAAthira Pharma Inc
04/11/20246:00AMGlobeNewswire Inc.Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s DiseaseNASDAQ:ATHAAthira Pharma Inc
04/03/20246:00AMGlobeNewswire Inc.Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual MeetingNASDAQ:ATHAAthira Pharma Inc
03/08/20246:00AMGlobeNewswire Inc.Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International ConferenceNASDAQ:ATHAAthira Pharma Inc
02/22/20243:34PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ATHAAthira Pharma Inc
02/22/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHAAthira Pharma Inc
02/22/20243:05PMGlobeNewswire Inc.Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business UpdatesNASDAQ:ATHAAthira Pharma Inc
02/16/20244:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
02/16/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
02/16/20243:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
02/16/20243:40PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ATHAAthira Pharma Inc
02/16/20243:37PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ATHAAthira Pharma Inc
02/16/20243:32PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ATHAAthira Pharma Inc
02/08/20243:02PMGlobeNewswire Inc.Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)NASDAQ:ATHAAthira Pharma Inc
01/08/20243:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
01/08/20243:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
01/08/20243:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
01/08/20243:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
01/08/20243:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHAAthira Pharma Inc
01/08/20246:11AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHAAthira Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:ATHA

Your Recent History

USOTC
HQGE
HQ Global Education (CE)
NYSE
GME
GameStop
USOTC
BLLB
Bell Buckle (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
TXTM
ProText Mobility (PK)
USOTC
RXMD
Progressive Care (QB)
USOTC
CLNV
Clean Vision (QB)
USOTC
CIVX
CTR Investments and Cons... (CE)
NASDAQ
HOLO
MicroCloud Hologram
USOTC
WDLF
Decentral Life (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
AHRO
Authentic (CE)
USOTC
KEGS
1812 Brewing (PK)
NYSE
AMC
AMC Entertainment
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved